| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | SUPT20HL1 BCL9L NCOA6 DTX1 NACA KDM3B NIBAN2 ZFPM1 ARID1B KMT2D TLE1 ZNF764 SMARCA2 NCOA1 IRF2BPL MYOCD MRTFA | 4.35e-06 | 562 | 165 | 17 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SUPT20HL1 BCL9L NCOA6 GATAD2A MAP1A RBM33 DTX1 NACA KDM3B PEX1 NIBAN2 ZFPM1 WNK1 SLC4A1 ARID1B KMT2D MAVS TLE1 ZNF764 SMARCA2 NCOA1 IRF2BPL MYOCD YTHDF2 MRTFA | 1.01e-05 | 1160 | 165 | 25 | GO:0030674 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.28e-05 | 37 | 165 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.46e-05 | 38 | 165 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SUPT20HL1 BCL9L NCOA6 GATAD2A MAP1A RBM33 DTX1 NACA SH3KBP1 KDM3B PEX1 NIBAN2 ZFPM1 WNK1 SLC4A1 ARID1B KMT2D MAVS TLE1 ZNF764 SMARCA2 NCOA1 IRF2BPL MYOCD YTHDF2 SEPTIN12 MRTFA | 1.78e-05 | 1356 | 165 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA6 DTX1 NACA NIBAN2 ARID1B KMT2D SMARCA2 NCOA1 MYOCD MRTFA | 4.55e-05 | 303 | 165 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.71e-05 | 11 | 165 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DIP2B MAP1A ABI3BP MAP4 MTSS1 WIPF3 CCDC187 CCDC88B KIF24 KLHL20 SLC4A1 FARP2 SHROOM1 PYCARD CLTC MAST1 DIAPH3 MYO18B PALLD MRTFA HTT | 2.93e-04 | 1099 | 165 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | miRNA binding | 6.59e-04 | 48 | 165 | 4 | GO:0035198 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.60e-04 | 21 | 165 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 9.96e-04 | 6 | 165 | 2 | GO:0003726 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.46e-05 | 66 | 165 | 6 | GO:0007019 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | ZC3H12A TUT4 UBAP2 TDRD9 PUM2 DCP1B UBAP2L NYNRIN TDRD6 YTHDF2 HTT | 1.00e-05 | 269 | 165 | 11 | GO:0036464 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | ZC3H12A TUT4 UBAP2 TDRD9 PUM2 DCP1B UBAP2L NYNRIN TDRD6 YTHDF2 HTT | 1.83e-05 | 287 | 165 | 11 | GO:0035770 |
| GeneOntologyCellularComponent | axon | BOC DIP2B MAP1A MAP4 PCLO MBP AAK1 LMTK3 CHRM1 ADCY9 KLHL20 CDKL5 PTK2B SYNJ2 MAST1 TNK2 BSN PALLD HTT | 8.15e-05 | 891 | 165 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | SWI/SNF complex | 8.74e-05 | 30 | 165 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.01e-04 | 12 | 165 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.13e-04 | 32 | 165 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | dendrite | DIP2B MAP1A ABI3BP PCLO ZDHHC5 PUM2 LMTK3 CHRM1 RTN1 ADCY9 KLHL20 CDKL5 PTK2B MAST1 TNK2 BSN HTT CYBA | 1.55e-04 | 858 | 165 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DIP2B MAP1A ABI3BP PCLO ZDHHC5 PUM2 LMTK3 CHRM1 RTN1 ADCY9 KLHL20 CDKL5 PTK2B MAST1 TNK2 BSN HTT CYBA | 1.60e-04 | 860 | 165 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | BOC DIP2B MAP1A ABI3BP PCLO MBP ZDHHC5 PUM2 LMTK3 CHRM1 RTN1 ADCY9 KLHL20 CDKL5 PTK2B PYCARD MAST1 TNK2 BSN PALLD HTT CYBA | 2.71e-04 | 1228 | 165 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOA6 CDX2 DEAF1 GATAD2A ZFPM1 TEAD3 IRF9 ATXN7 TLE1 ARID2 GLIS2 NCOA1 MYOCD | 2.81e-04 | 596 | 165 | 14 | GO:0005667 |
| GeneOntologyCellularComponent | actin filament bundle | 3.51e-04 | 118 | 165 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 6.10e-04 | 5 | 165 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.88e-04 | 96 | 165 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA6 DEAF1 GATAD2A BICRA KDM3B CHD8 KDM6B ADAR IRF9 INTS6 ARID1B KMT2D UBAP2L ATXN7 TLE1 ARID2 CLTC SMARCA2 NCOA1 MYOCD POM121B | 1.25e-03 | 1377 | 165 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SUPT20HL1 CDX2 DEAF1 GATAD2A BICRA KDM3B CHD8 ZFPM1 TEAD3 RFX1 ZC3H6 CIC CASZ1 KANSL3 IRF9 ARID1B ATXN7 ARID2 SMARCA2 ZFHX2 NCOA1 MYOCD HSF4 | 1.39e-03 | 1480 | 165 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.60e-03 | 107 | 165 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.60e-03 | 107 | 165 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.68e-03 | 8 | 165 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | cell leading edge | PDE4A ABI3BP RAPH1 MTSS1 AAK1 CTTNBP2NL CDKL5 PTK2B SYNJ2 ARHGEF26 PALLD | 2.12e-03 | 500 | 165 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | clathrin complex | 2.15e-03 | 9 | 165 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP1A ABI3BP MAP4 PCLO ZDHHC5 CHRM1 RTN1 CDKL5 PTK2B GLRA2 BSN | 2.23e-03 | 503 | 165 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | actomyosin | 2.37e-03 | 117 | 165 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | distal axon | 2.45e-03 | 435 | 165 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | neuronal cell body | BOC DIP2B MAP1A PCLO MBP PUM2 RTN1 PTK2B PYCARD MAST1 TNK2 BSN PALLD HTT CYBA | 2.59e-03 | 835 | 165 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | bBAF complex | 2.67e-03 | 10 | 165 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | cell body | BOC DIP2B MAP1A PCLO MBP PUM2 RTN1 PTK2B PYCARD MAST1 TNK2 BSN PALLD WNK4 HTT CYBA | 2.85e-03 | 929 | 165 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.94e-03 | 75 | 165 | 4 | GO:0035097 | |
| Domain | DUF3697_Uba2 | 7.11e-05 | 2 | 158 | 2 | IPR022166 | |
| Domain | Znf_piccolo | 7.11e-05 | 2 | 158 | 2 | IPR008899 | |
| Domain | zf-piccolo | 7.11e-05 | 2 | 158 | 2 | PF05715 | |
| Domain | DUF3697 | 7.11e-05 | 2 | 158 | 2 | PF12478 | |
| Domain | BAT2_N | 2.12e-04 | 3 | 158 | 2 | PF07001 | |
| Domain | BAT2_N | 2.12e-04 | 3 | 158 | 2 | IPR009738 | |
| Domain | EGD2/NACA | 2.12e-04 | 3 | 158 | 2 | IPR016641 | |
| Domain | PRRC2 | 2.12e-04 | 3 | 158 | 2 | IPR033184 | |
| Domain | NAC | 6.99e-04 | 5 | 158 | 2 | SM01407 | |
| Domain | INTEGRASE | 6.99e-04 | 5 | 158 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 6.99e-04 | 5 | 158 | 2 | IPR001584 | |
| Domain | BRK | 1.04e-03 | 6 | 158 | 2 | SM00592 | |
| Domain | ADEAMc | 1.04e-03 | 6 | 158 | 2 | SM00552 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 1.04e-03 | 6 | 158 | 2 | IPR002715 | |
| Domain | OSR1_C | 1.04e-03 | 6 | 158 | 2 | PF12202 | |
| Domain | A_deamin | 1.04e-03 | 6 | 158 | 2 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 1.04e-03 | 6 | 158 | 2 | PS50141 | |
| Domain | BRK_domain | 1.04e-03 | 6 | 158 | 2 | IPR006576 | |
| Domain | NAC | 1.04e-03 | 6 | 158 | 2 | PF01849 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.04e-03 | 6 | 158 | 2 | IPR024678 | |
| Domain | NAC_AB | 1.04e-03 | 6 | 158 | 2 | PS51151 | |
| Domain | BRK | 1.04e-03 | 6 | 158 | 2 | PF07533 | |
| Domain | A_deamin | 1.04e-03 | 6 | 158 | 2 | IPR002466 | |
| Pubmed | BCL9L NCOA6 CEP85 UBAP2 DEAF1 GATAD2A RBM33 BICRA NACA SH3KBP1 PUM2 DIDO1 CC2D1A CHD8 PROSER1 TEAD3 RFX1 WASHC2A CIC KANSL3 IRF9 ARID1B KMT2D FAM120A UBN1 DCP1B UBAP2L ATXN7 TLE1 ARID2 SMARCA2 NCOA1 IRF2BPL PRRC2A YTHDF2 PRRC2B | 1.72e-16 | 1429 | 166 | 36 | 35140242 | |
| Pubmed | NCOA6 CEP85 UBAP2 RAPH1 MAP4 KDM3B PTPN23 DIDO1 CC2D1A CHD8 RFX1 ADAR ARID1B KMT2D UBAP2L ARID2 LPP CLTC DIAPH3 PRRC2A PALLD PRRC2B HTT | 2.56e-15 | 549 | 166 | 23 | 38280479 | |
| Pubmed | NCOA6 CEP85 GATAD2A MAP1A RAPH1 RBM33 NACA PTPN23 DIDO1 CHD8 RFX1 WASHC2A ADAR CTTNBP2NL CIC KANSL3 ARID1B ARID2 SMARCA2 IRF2BPL MRTFA | 1.40e-14 | 472 | 166 | 21 | 38943005 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B NCOA6 DEAF1 RAPH1 MAP4 AAK1 KDM3B PUM2 DIDO1 NIBAN2 ZFPM1 RFX1 CTTNBP2NL CIC KANSL3 KMT2D UBN1 UBAP2L ATXN7 CLTC SMARCA2 IRF2BPL PRRC2A NOTCH2 MRTFA | 5.28e-14 | 774 | 166 | 25 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 DIP2B NCOA6 AMER1 UBAP2 RAPH1 MAP4 AAK1 KDM3B CC2D1A PLEKHG2 WNK1 NCKAP5L DENND2B CIC PPP4R4 PTK2B DCP1B SYNJ2 CASKIN2 LPP PALLD YTHDF2 WNK4 NOTCH2 OTOG | 7.44e-14 | 861 | 166 | 26 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 PDE4A ZNF628 BICRA ZDHHC5 KDM3B CC2D1A CHD8 ZFPM1 KDM6B WNK1 WASHC2A CIC CASZ1 ADCY9 PLEKHH3 KANSL3 DACT1 KMT2D UBN1 CELSR2 ADAMTS7 HPS6 TNK2 HMGXB3 NOTCH2 PRRC2B HTT | 5.29e-13 | 1105 | 166 | 28 | 35748872 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 UBAP2 MAP1A RAPH1 MAP4 NACA AAK1 KDM3B PUM2 PTPN23 DIDO1 CC2D1A NIBAN2 WNK1 ADAR RTN1 CIC MAVS UBAP2L ARID2 LPP PRRC2A PALLD YTHDF2 PRRC2B | 3.28e-12 | 934 | 166 | 25 | 33916271 |
| Pubmed | BCL9L NCOA6 RBM33 KDM3B CHD8 TEAD3 CIC CASZ1 KANSL3 ARID1B KMT2D TLE1 SMARCA2 NCOA1 PRRC2B | 3.83e-12 | 268 | 166 | 15 | 33640491 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TUT4 PCBP3 CEP85 UBAP2 MAP1A MAP4 RBM33 AAK1 PUM2 CC2D1A NIBAN2 WASHC2A ADAR STT3B FAM120A SYNJ2 UBAP2L DIAPH3 PRRC2A PALLD YTHDF2 PRRC2B | 6.44e-12 | 724 | 166 | 22 | 36232890 |
| Pubmed | NCOA6 UBAP2 NACA MTSS1 AAK1 KDM3B DIDO1 CHD8 KDM6B NACAD CTTNBP2NL ADCY9 KANSL3 ARID1B SYNJ2 CASKIN2 HMGXB3 IGSF1 BSN | 1.14e-11 | 529 | 166 | 19 | 14621295 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | GATAD2A MAP1A MAP4 AAK1 KDM3B NAA80 CHD8 NIBAN2 CTTNBP2NL KANSL3 UBN1 MAVS UBAP2L ATXN7 LPP PALLD YTHDF2 | 5.47e-11 | 444 | 166 | 17 | 34795231 |
| Pubmed | TUT4 UBAP2 RBM33 NACA KDM3B PUM2 WNK1 NCKAP5L WASHC2A RTN1 ADCY9 STT3B FARP2 ARID1B FAM120A MAVS DCP1B SYNJ2 TLE1 LPP YTHDF2 | 5.96e-11 | 733 | 166 | 21 | 34672954 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EHBP1 ZC3H12A AMER1 CEP85 RAPH1 RBM33 AAK1 KDM3B CC2D1A WNK1 NCKAP5L WASHC2A KLHL20 FARP2 WDR91 SHROOM1 DCP1B UBAP2L HPS6 LPP VPS28 DIAPH3 YTHDF2 MRTFA | 1.85e-10 | 1038 | 166 | 24 | 26673895 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 UBAP2 MAP1A BICRA DTX1 LMTK3 WNK1 CIC UBN1 ARID2 CLTC TNK2 IRF2BPL BSN WNK4 MRTFA | 3.14e-10 | 430 | 166 | 16 | 35044719 |
| Pubmed | GATAD2A MAP4 AAK1 DIDO1 CC2D1A CHD8 NIBAN2 WNK1 ADAR CTTNBP2NL FAM120A MAVS DCP1B UBAP2L PRRC2A PALLD MRTFA | 3.72e-10 | 503 | 166 | 17 | 16964243 | |
| Pubmed | MAP1A MAP4 PCLO SH3KBP1 AAK1 ZDHHC5 GPR37L1 LMTK3 RTN1 ADCY9 UBAP2L BSN PRRC2A HTT | 1.50e-09 | 347 | 166 | 14 | 17114649 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EHBP1 UBAP2 RAPH1 MAP4 SH3KBP1 AAK1 ZDHHC5 CC2D1A NIBAN2 ADCY9 CDKL5 MAVS SYNJ2 CASKIN2 LPP DIAPH3 NOTCH2 | 2.15e-09 | 565 | 166 | 17 | 25468996 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EHBP1 DIP2B TUT4 AMER1 MAP4 BICRA MBP AAK1 ANKMY1 DENND2B CASZ1 PPP4R4 FARP2 KANSL3 INTS6 FAM120A SYNJ2 UBAP2L ATXN7 LPP SMARCA2 MAST1 ZFHX2 TNK2 ARHGEF26 NOTCH2 HTT | 2.48e-09 | 1489 | 166 | 27 | 28611215 |
| Pubmed | NCOA6 DEAF1 GATAD2A MAP4 RBM33 BICRA KDM3B DIDO1 CC2D1A CHD8 RFX1 ADAR CIC KANSL3 ARID1B KMT2D FAM120A ARID2 CLTC SMARCA2 NCOA1 PRRC2A PRRC2B | 3.27e-09 | 1103 | 166 | 23 | 34189442 | |
| Pubmed | EHBP1 MAP1A ABI3BP RBM33 BICRA PTPN23 CHD8 WNK1 NCKAP5L CCDC88B CIC SYNJ2 ARID2 CLTC TNK2 | 1.42e-08 | 486 | 166 | 15 | 20936779 | |
| Pubmed | ZFPM1 LMTK3 NACAD CASZ1 TTC7B UBAP2L ATXN7 NYNRIN MAST1 NCOA1 BSN | 1.83e-08 | 233 | 166 | 11 | 37704626 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | CEP85 MAP1A MAP4 NCKAP5L KRBA1 KMT2D UBN1 DIAPH3 PALLD NOTCH2 | 2.19e-08 | 184 | 166 | 10 | 32908313 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L AMER1 RAPH1 MAP4 ZDHHC5 DIDO1 CCDC88B SHROOM1 MYO18B PRRC2A PALLD PRRC2B PLAAT5 | 2.26e-08 | 361 | 166 | 13 | 26167880 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 PCBP3 UBAP2 DEAF1 GATAD2A MAP4 RBM33 BICRA DIDO1 CHD8 RFX1 ADAR CIC ARID1B UBN1 UBAP2L ARID2 CLTC PRRC2A YTHDF2 | 3.46e-08 | 954 | 166 | 20 | 36373674 |
| Pubmed | 3.97e-08 | 104 | 166 | 8 | 9205841 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA6 CEP85 RBM33 PUM2 TEAD3 CIC ARID1B KMT2D DCP1B TLE1 SMARCA2 YTHDF2 PRRC2B | 4.81e-08 | 457 | 166 | 14 | 32344865 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | TUT4 PCBP3 PCLO PUM2 WNK1 ADAR PLEKHH3 FAM120A UBAP2L NYNRIN PRRC2A YTHDF2 WNK4 PRRC2B | 5.50e-08 | 462 | 166 | 14 | 31138677 |
| Pubmed | 7.15e-08 | 157 | 166 | 9 | 30186101 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | KDM3B DIDO1 ADAR CASZ1 ARID1B KMT2D ARID2 SMARCA2 NCOA1 IRF2BPL | 1.18e-07 | 220 | 166 | 10 | 35785414 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA6 BICRA CHD8 PROSER1 ARID1B KMT2D TLE1 ARID2 SMARCA2 NCOA1 PRRC2B | 1.40e-07 | 351 | 166 | 12 | 38297188 |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 2.06e-07 | 53 | 166 | 6 | 15572359 | |
| Pubmed | 2.40e-07 | 12 | 166 | 4 | 14557543 | ||
| Pubmed | CDX2 DEAF1 ZDHHC5 KDM3B DIDO1 RFX1 ZC3H6 CIC KRBA1 ZNF764 ARID2 GLIS2 LPP SMARCA2 NCOA1 HMGXB3 MRTFA | 3.75e-07 | 808 | 166 | 17 | 20412781 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | UBAP2 MAP4 PUM2 ADAR CTTNBP2NL FAM120A UBAP2L LPP PRRC2A PALLD YTHDF2 | 3.83e-07 | 315 | 166 | 11 | 26777405 |
| Pubmed | NCOA6 GATAD2A KDM3B RFX1 CIC CASZ1 PPP4R4 ARID1B KMT2D ATXN7 ARID2 SMARCA2 NCOA1 BSN PRRC2B | 4.75e-07 | 638 | 166 | 15 | 31182584 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | GATAD2A BICRA PCLO NCKAP5L CASZ1 ZNF518A ARID1B KMT2D TLE1 ARID2 SMARCA2 NCOA1 | 5.35e-07 | 398 | 166 | 12 | 35016035 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EHBP1 DIP2B MBP ZDHHC5 NIBAN2 ADCY9 STT3B FARP2 CDKL5 CELSR2 CASKIN2 DIAPH3 ARHGEF26 NOTCH2 | 6.81e-07 | 569 | 166 | 14 | 30639242 |
| Pubmed | 7.44e-07 | 152 | 166 | 8 | 38360978 | ||
| Pubmed | EHBP1 ZDHHC5 PTPN23 WNK1 CASZ1 PPP4R4 FARP2 KRBA1 FAM120A ARID2 IRF2BPL POM121B PALLD | 8.03e-07 | 493 | 166 | 13 | 15368895 | |
| Pubmed | DIP2B PDE4A UBAP2 SH3KBP1 AAK1 DIDO1 CHD8 LMTK3 RTN1 WDR91 FAM120A CELSR2 UBAP2L CLTC BSN ARHGEF26 PRRC2A PRRC2B | 9.21e-07 | 963 | 166 | 18 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CEP85 MAP1A RBM33 WNK1 NCKAP5L WASHC2A CIC KANSL3 UBN1 ARID2 CLTC DIAPH3 BSN PRRC2B | 1.00e-06 | 588 | 166 | 14 | 38580884 |
| Pubmed | 1.49e-06 | 225 | 166 | 9 | 12168954 | ||
| Pubmed | PCBP3 DEAF1 AAK1 KDM3B RFX1 WASHC2A ADAR CHRM1 RTN1 CASZ1 IRF9 FAM120A TTC7B GLIS2 MAST1 NCOA1 BSN PRRC2B | 1.71e-06 | 1006 | 166 | 18 | 15226823 | |
| Pubmed | EHBP1 MAP4 AAK1 ZDHHC5 PTPN23 CC2D1A NIBAN2 ADCY9 STT3B UBAP2L DIAPH3 ARHGEF26 PRRC2A PALLD YTHDF2 | 1.73e-06 | 708 | 166 | 15 | 39231216 | |
| Pubmed | TUT4 GATAD2A MAP1A ADAMTS1 BICRA PEX1 CHD8 NCKAP5L ADCY9 SLC4A1 ZNF518A INTS6 ARID1B FAM120A ATXN7 ARID2 SMARCA2 NOTCH2 PRRC2B | 1.79e-06 | 1116 | 166 | 19 | 31753913 | |
| Pubmed | EHBP1 BCL9L TUT4 UBAP2 MAP1A MAP4 PCLO NACA SH3KBP1 AAK1 WASHC2A RTN1 NACAD STT3B CDKL5 CELSR2 UBAP2L CLTC BSN | 2.41e-06 | 1139 | 166 | 19 | 36417873 | |
| Pubmed | 3.01e-06 | 83 | 166 | 6 | 28794006 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.90e-06 | 332 | 166 | 10 | 32786267 | |
| Pubmed | 7.96e-06 | 209 | 166 | 8 | 36779422 | ||
| Pubmed | 8.06e-06 | 27 | 166 | 4 | 29374058 | ||
| Pubmed | 1.03e-05 | 60 | 166 | 5 | 34761192 | ||
| Pubmed | 1.08e-05 | 29 | 166 | 4 | 36800290 | ||
| Pubmed | 1.08e-05 | 29 | 166 | 4 | 19279220 | ||
| Pubmed | CEP85 RAPH1 ZDHHC5 PTPN23 NIBAN2 NCKAP5L CIC ADCY9 PPP4R4 ARID1B KMT2D TTC7B CASKIN2 LPP CLTC PRRC2A PRRC2B | 1.23e-05 | 1049 | 166 | 17 | 27880917 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.25e-05 | 10 | 166 | 3 | 23129809 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.38e-05 | 108 | 166 | 6 | 19531213 | |
| Pubmed | DIP2B CEP85 NACA KDM3B PEX1 DIDO1 CHD8 FARP2 FAM120A CASKIN2 PALLD YTHDF2 PRRC2B | 1.60e-05 | 650 | 166 | 13 | 38777146 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.64e-05 | 231 | 166 | 8 | 16452087 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.70e-05 | 232 | 166 | 8 | 25515538 | |
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 10847592 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DIP2B CHD8 LMTK3 WASHC2A INTS6 FAM120A TTC7B UBAP2L PRRC2A PRRC2B HTT | 1.94e-05 | 475 | 166 | 11 | 31040226 |
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 2.08e-05 | 34 | 166 | 4 | 30894540 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.26e-05 | 2 | 166 | 2 | 23403927 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.26e-05 | 2 | 166 | 2 | 26793095 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21704025 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 2.26e-05 | 2 | 166 | 2 | 37676945 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.26e-05 | 2 | 166 | 2 | 21935939 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22294159 | ||
| Pubmed | Huntingtin is associated with cytomatrix proteins at the presynaptic terminal. | 2.26e-05 | 2 | 166 | 2 | 25461618 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 34525337 | ||
| Pubmed | Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. | 2.26e-05 | 2 | 166 | 2 | 16899520 | |
| Pubmed | Negative regulation of MAVS-mediated innate immune response by ASC. | 2.26e-05 | 2 | 166 | 2 | 29280086 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25113964 | ||
| Pubmed | Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC. | 2.26e-05 | 2 | 166 | 2 | 29846116 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 35633597 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12524348 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23821607 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17322171 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 2.26e-05 | 2 | 166 | 2 | 25652077 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31928221 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28555636 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12671053 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 14970199 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 27088725 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19205907 | ||
| Pubmed | Bacterial RNA is recognized by different sets of immunoreceptors. | 2.26e-05 | 2 | 166 | 2 | 19662634 | |
| Pubmed | Coronary artery superoxide production and nox isoform expression in human coronary artery disease. | 2.26e-05 | 2 | 166 | 2 | 16293794 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22917585 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 27321892 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16820787 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 32493491 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28867767 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 29212017 | ||
| Pubmed | EHBP1 CDX2 CEP85 GATAD2A RBM33 NACA ZDHHC5 PUM2 CC2D1A STT3B MAVS LPP PALLD YTHDF2 NOTCH2 PRRC2B | 2.84e-05 | 1007 | 166 | 16 | 34597346 | |
| Pubmed | 2.92e-05 | 37 | 166 | 4 | 24335282 | ||
| Pubmed | NCOA6 KDM3B NIBAN2 PPP1R15A RFX1 DENND2B ZNF518A ARID1B KMT2D DCP1B DIAPH3 NOTCH2 | 2.95e-05 | 591 | 166 | 12 | 15231748 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 2.95e-05 | 13 | 166 | 3 | 17761849 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 2.99e-05 | 327 | 166 | 9 | 15592455 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBAP2 MAP4 NACA AAK1 KDM3B PTPN23 NIBAN2 WNK1 ADAR CTTNBP2NL MAVS UBAP2L LPP CLTC SMARCA2 IRF2BPL VPS28 PALLD PRRC2B | 3.11e-05 | 1367 | 166 | 19 | 32687490 |
| Interaction | CPEB4 interactions | TUT4 CEP85 UBAP2 PUM2 CC2D1A FAM120A DCP1B UBAP2L SMARCA2 PRRC2A YTHDF2 PRRC2B | 5.01e-09 | 156 | 162 | 12 | int:CPEB4 |
| Interaction | WWTR1 interactions | NCOA6 CEP85 UBAP2 RAPH1 PTPN23 DIDO1 CHD8 TEAD3 ADAR ARID1B KMT2D ARID2 LPP CLTC DIAPH3 PRRC2A PRRC2B HTT | 9.14e-09 | 422 | 162 | 18 | int:WWTR1 |
| Interaction | EGR2 interactions | BCL9L NCOA6 BICRA DTX1 PROSER1 ARID1B KMT2D TLE1 ARID2 SMARCA2 NCOA1 PRRC2B | 1.41e-08 | 171 | 162 | 12 | int:EGR2 |
| Interaction | TOP3B interactions | NCOA6 PDE4A UBAP2 ZNF628 RBM33 BICRA ZDHHC5 KDM3B CC2D1A CHD8 ZFPM1 KDM6B WNK1 WASHC2A CIC CASZ1 ADCY9 PLEKHH3 KANSL3 DACT1 KMT2D FAM120A UBN1 CELSR2 ADAMTS7 UBAP2L HPS6 TNK2 HMGXB3 PRRC2A YTHDF2 NOTCH2 PRRC2B HTT | 1.71e-08 | 1470 | 162 | 34 | int:TOP3B |
| Interaction | ZFP36 interactions | TUT4 CEP85 SH3KBP1 PUM2 NCKAP5L FAM120A DCP1B UBAP2L NYNRIN PRRC2A YTHDF2 PRRC2B | 2.67e-08 | 181 | 162 | 12 | int:ZFP36 |
| Interaction | SP7 interactions | BCL9L NCOA6 RBM33 BICRA PROSER1 RFX1 CIC ARID1B KMT2D TLE1 ARID2 SMARCA2 NCOA1 PRRC2B | 1.75e-07 | 304 | 162 | 14 | int:SP7 |
| Interaction | PPIA interactions | NCOA6 CEP85 GATAD2A MAP1A RAPH1 RBM33 NACA PTPN23 DIDO1 CHD8 RFX1 WASHC2A ADAR CTTNBP2NL CIC KANSL3 CDKL5 ARID1B MAVS ARID2 SMARCA2 IRF2BPL YTHDF2 MRTFA | 1.86e-07 | 888 | 162 | 24 | int:PPIA |
| Interaction | MEX3B interactions | TUT4 CEP85 UBAP2 PUM2 CC2D1A NCKAP5L FAM120A DCP1B UBAP2L PRRC2A YTHDF2 PRRC2B | 2.50e-07 | 222 | 162 | 12 | int:MEX3B |
| Interaction | DAZL interactions | TUT4 CEP85 UBAP2 RBM33 PUM2 FAM120A UBAP2L PRRC2A YTHDF2 PRRC2B | 2.77e-07 | 145 | 162 | 10 | int:DAZL |
| Interaction | NAA40 interactions | EHBP1 UBAP2 MAP1A RAPH1 MAP4 NACA AAK1 KDM3B PUM2 PTPN23 DIDO1 CC2D1A NIBAN2 WNK1 ADAR RTN1 CIC MAVS UBAP2L ARID2 LPP PRRC2A PALLD YTHDF2 PRRC2B | 2.86e-07 | 978 | 162 | 25 | int:NAA40 |
| Interaction | CPEB1 interactions | CEP85 UBAP2 PUM2 CC2D1A FAM120A DCP1B UBAP2L PRRC2A YTHDF2 PRRC2B | 2.95e-07 | 146 | 162 | 10 | int:CPEB1 |
| Interaction | SOX7 interactions | 3.15e-07 | 82 | 162 | 8 | int:SOX7 | |
| Interaction | NUP35 interactions | BCL9L NCOA6 CEP85 RBM33 PUM2 CIC KLHL20 ARID1B KMT2D MAVS DCP1B TLE1 GLRA2 SMARCA2 YTHDF2 PRRC2B | 3.37e-07 | 424 | 162 | 16 | int:NUP35 |
| Interaction | YWHAH interactions | EHBP1 DIP2B NCOA6 AMER1 UBAP2 AAK1 KDM3B CC2D1A PLEKHG2 WNK1 NCKAP5L DENND2B CIC PPP4R4 SHROOM1 DCP1B SYNJ2 CASKIN2 LPP MAST1 NCOA1 PALLD YTHDF2 NOTCH2 HTT OTOG | 7.41e-07 | 1102 | 162 | 26 | int:YWHAH |
| Interaction | SOX10 interactions | 7.70e-07 | 92 | 162 | 8 | int:SOX10 | |
| Interaction | PFN1 interactions | MAP1A RAPH1 PCLO WIPF3 AAK1 NAA80 WNK1 CTTNBP2NL DCP1B SYNJ2 TLE1 LPP CLTC DIAPH3 PALLD MRTFA HTT | 7.81e-07 | 509 | 162 | 17 | int:PFN1 |
| Interaction | R3HDM2 interactions | 1.01e-06 | 129 | 162 | 9 | int:R3HDM2 | |
| Interaction | CRX interactions | BCL9L BICRA PROSER1 ARID1B KMT2D ATXN7 TLE1 ARID2 GLIS2 SMARCA2 NCOA1 PRRC2B | 1.05e-06 | 254 | 162 | 12 | int:CRX |
| Interaction | SOX9 interactions | 1.16e-06 | 97 | 162 | 8 | int:SOX9 | |
| Interaction | PML interactions | GATAD2A MAP1A MAP4 AAK1 KDM3B NAA80 CHD8 NIBAN2 CTTNBP2NL KLHL20 KANSL3 INTS6 FAM120A UBN1 MAVS UBAP2L ATXN7 PYCARD GLIS2 LPP PALLD YTHDF2 HTT | 1.67e-06 | 933 | 162 | 23 | int:PML |
| Interaction | SMG7 interactions | NCOA6 CEP85 RBM33 CHD8 ARID1B KMT2D FAM120A UBAP2L TLE1 NCOA1 PRRC2A YTHDF2 PRRC2B | 1.93e-06 | 319 | 162 | 13 | int:SMG7 |
| Interaction | ALG13 interactions | RBM33 PUM2 ARID1B KMT2D FAM120A UBAP2L TLE1 PRRC2A YTHDF2 PRRC2B | 2.34e-06 | 183 | 162 | 10 | int:ALG13 |
| Interaction | HNF4A interactions | NCOA6 BICRA CIC KANSL3 ARID1B KMT2D UBN1 ATXN7 TLE1 ARID2 SMARCA2 NCOA1 | 2.40e-06 | 275 | 162 | 12 | int:HNF4A |
| Interaction | BAG2 interactions | NCOA6 TUT4 UBAP2 RBM33 AAK1 KDM3B PEX1 PTPN23 WNK1 RFX1 CIC SHROOM1 MAVS CLTC IRF2BPL PALLD MRTFA HTT | 2.80e-06 | 622 | 162 | 18 | int:BAG2 |
| Interaction | HSPA2 interactions | UBAP2 PTPN23 CC2D1A CTTNBP2NL CIC ADAD2 ARID1B SHROOM1 MAVS CLTC NCOA1 PALLD SEPTIN12 MRTFA HTT | 2.81e-06 | 440 | 162 | 15 | int:HSPA2 |
| Interaction | SMAP2 interactions | TUT4 CEP85 UBAP2 PUM2 PTPN23 UBAP2L PRRC2A YTHDF2 NOTCH2 PRRC2B | 3.13e-06 | 189 | 162 | 10 | int:SMAP2 |
| Interaction | HNF1B interactions | BICRA PROSER1 CIC ARID1B KMT2D UBN1 TLE1 ARID2 SMARCA2 PRRC2B | 3.28e-06 | 190 | 162 | 10 | int:HNF1B |
| Interaction | CELF1 interactions | TUT4 CEP85 UBAP2 RBM33 PUM2 ADAR FAM120A UBAP2L NYNRIN PRRC2A YTHDF2 PRRC2B | 3.86e-06 | 288 | 162 | 12 | int:CELF1 |
| Interaction | KLF5 interactions | NCOA6 CDX2 CIC ARID1B KMT2D TLE1 ARID2 SMARCA2 PRRC2A PRRC2B | 4.13e-06 | 195 | 162 | 10 | int:KLF5 |
| Interaction | AR interactions | BCL9L NCOA6 RBM33 KDM3B DIDO1 CHD8 TEAD3 ADAR CIC CASZ1 KANSL3 ARID1B KMT2D UBAP2L TLE1 ARID2 HPS6 CLTC SMARCA2 NCOA1 TNK2 IRF2BPL PRRC2B | 4.65e-06 | 992 | 162 | 23 | int:AR |
| Interaction | IRF4 interactions | 5.56e-06 | 85 | 162 | 7 | int:IRF4 | |
| Interaction | RBM47 interactions | TUT4 PCBP3 CEP85 UBAP2 PUM2 FAM120A UBAP2L PRRC2A YTHDF2 PRRC2B | 6.16e-06 | 204 | 162 | 10 | int:RBM47 |
| Interaction | GSK3B interactions | CDX2 DEAF1 MAP1A MAP4 RBM33 NACA NIBAN2 ZFPM1 WASHC2A RTN1 CTTNBP2NL KRBA1 FAM120A DCP1B TLE1 LPP CLTC MYOCD PALLD NOTCH2 MRTFA | 6.60e-06 | 868 | 162 | 21 | int:GSK3B |
| Interaction | SOX5 interactions | 6.64e-06 | 162 | 162 | 9 | int:SOX5 | |
| Interaction | LSM14A interactions | TUT4 CEP85 UBAP2 PUM2 CIC FAM120A DCP1B UBAP2L PRRC2A YTHDF2 PRRC2B | 8.57e-06 | 260 | 162 | 11 | int:LSM14A |
| Interaction | YTHDF2 interactions | TUT4 CEP85 UBAP2 PUM2 PTPN23 CIC FAM120A DCP1B UBAP2L PRRC2A YTHDF2 PRRC2B | 8.71e-06 | 312 | 162 | 12 | int:YTHDF2 |
| Interaction | PRMT2 interactions | 8.75e-06 | 91 | 162 | 7 | int:PRMT2 | |
| Interaction | ZC3H7A interactions | CEP85 UBAP2 PUM2 CC2D1A FAM120A UBAP2L NYNRIN PRRC2A YTHDF2 PRRC2B | 9.78e-06 | 215 | 162 | 10 | int:ZC3H7A |
| Interaction | PAX9 interactions | 1.04e-05 | 130 | 162 | 8 | int:PAX9 | |
| Interaction | SOX17 interactions | 1.16e-05 | 95 | 162 | 7 | int:SOX17 | |
| Interaction | ERG interactions | 1.34e-05 | 223 | 162 | 10 | int:ERG | |
| Interaction | CNOT2 interactions | 1.42e-05 | 178 | 162 | 9 | int:CNOT2 | |
| Interaction | RAB5A interactions | EHBP1 MAP4 RBM33 SH3KBP1 MTSS1 ZDHHC5 PTPN23 CC2D1A NIBAN2 WASHC2A RTN1 ADCY9 FAM120A MAVS PYCARD DIAPH3 NOTCH2 HTT | 1.58e-05 | 706 | 162 | 18 | int:RAB5A |
| Interaction | TNRC6A interactions | NCOA6 CEP85 GATAD2A WNK1 DCP1B UBAP2L NYNRIN CLTC PRRC2A YTHDF2 PRRC2B | 1.71e-05 | 280 | 162 | 11 | int:TNRC6A |
| Interaction | GCM1 interactions | 1.78e-05 | 68 | 162 | 6 | int:GCM1 | |
| Interaction | DUSP16 interactions | TUT4 AMER1 CEP85 PEX1 PTPN23 NCKAP5L WASHC2A SHROOM1 NYNRIN HTT | 2.27e-05 | 237 | 162 | 10 | int:DUSP16 |
| Interaction | SUMO2 interactions | DIP2B MAP4 NACA DIDO1 CHD8 NIBAN2 TEAD3 LMTK3 CIC UBAP2L ATXN7 ARID2 HPS6 CLTC PALLD HTT | 2.34e-05 | 591 | 162 | 16 | int:SUMO2 |
| Interaction | FAM120C interactions | 2.48e-05 | 191 | 162 | 9 | int:FAM120C | |
| Interaction | VASP interactions | DIP2B MAP1A RAPH1 AAK1 PTPN23 RTN1 CTTNBP2NL SYNJ2 LPP PALLD MRTFA | 2.69e-05 | 294 | 162 | 11 | int:VASP |
| Interaction | YTHDF3 interactions | TUT4 CEP85 UBAP2 PUM2 FAM120A DCP1B UBAP2L PRRC2A YTHDF2 PRRC2B | 3.12e-05 | 246 | 162 | 10 | int:YTHDF3 |
| Interaction | PAX8 interactions | 3.21e-05 | 111 | 162 | 7 | int:PAX8 | |
| Interaction | GATA2 interactions | 3.43e-05 | 199 | 162 | 9 | int:GATA2 | |
| Interaction | ASF1A interactions | NCOA6 GATAD2A BICRA CHD8 CASZ1 ARID1B KMT2D UBN1 ARID2 VPS28 | 3.46e-05 | 249 | 162 | 10 | int:ASF1A |
| Interaction | TBR1 interactions | 3.60e-05 | 113 | 162 | 7 | int:TBR1 | |
| Interaction | FEV interactions | 4.00e-05 | 203 | 162 | 9 | int:FEV | |
| Interaction | SOX6 interactions | 4.06e-05 | 157 | 162 | 8 | int:SOX6 | |
| Interaction | DENND2A interactions | 4.13e-05 | 9 | 162 | 3 | int:DENND2A | |
| Interaction | FBLN5 interactions | 4.45e-05 | 159 | 162 | 8 | int:FBLN5 | |
| Interaction | HELZ interactions | TUT4 CEP85 PUM2 KLHL20 DCP1B UBAP2L CLTC PRRC2A YTHDF2 PRRC2B | 4.52e-05 | 257 | 162 | 10 | int:HELZ |
| Interaction | ACTC1 interactions | GATAD2A RAPH1 RBM33 BICRA SH3KBP1 WIPF3 KDM3B PEX1 NAA80 WASHC2A CIC SLC4A1 ARID1B ARID2 CLTC SMARCA2 MRTFA | 4.55e-05 | 694 | 162 | 17 | int:ACTC1 |
| Interaction | FOS interactions | NCOA6 DEAF1 NACA CIC ARID1B KMT2D UBN1 TLE1 ARID2 SMARCA2 NCOA1 | 4.62e-05 | 312 | 162 | 11 | int:FOS |
| Interaction | RBMS1 interactions | 4.66e-05 | 207 | 162 | 9 | int:RBMS1 | |
| Interaction | CDH1 interactions | EHBP1 UBAP2 RAPH1 MAP4 SH3KBP1 AAK1 ZDHHC5 CC2D1A NIBAN2 ADCY9 FARP2 CDKL5 MAVS SYNJ2 CASKIN2 LPP DIAPH3 NOTCH2 | 4.78e-05 | 768 | 162 | 18 | int:CDH1 |
| Interaction | SH3KBP1 interactions | RAPH1 MAP4 SH3KBP1 CCDC88B CDKL5 PTK2B SYNJ2 CASKIN2 ZNF764 CLTC PRRC2A | 5.03e-05 | 315 | 162 | 11 | int:SH3KBP1 |
| Interaction | DCP1A interactions | 6.03e-05 | 166 | 162 | 8 | int:DCP1A | |
| Interaction | YWHAG interactions | EHBP1 NCOA6 AMER1 UBAP2 RAPH1 AAK1 KDM3B PLEKHG2 WNK1 NCKAP5L DENND2B CIC PPP4R4 FARP2 SHROOM1 DCP1B SYNJ2 CASKIN2 CLTC TNK2 YTHDF2 NOTCH2 HTT OTOG | 6.12e-05 | 1248 | 162 | 24 | int:YWHAG |
| Interaction | GARRE1 interactions | 6.29e-05 | 167 | 162 | 8 | int:GARRE1 | |
| Interaction | MEX3A interactions | BCL9L CDX2 CHD8 ADAR UBN1 UBAP2L CLTC IRF2BPL HMGXB3 PRRC2A YTHDF2 PRRC2B | 6.67e-05 | 384 | 162 | 12 | int:MEX3A |
| Interaction | TPRX2 interactions | 8.66e-05 | 56 | 162 | 5 | int:TPRX2 | |
| Interaction | ANKRD17 interactions | 9.16e-05 | 226 | 162 | 9 | int:ANKRD17 | |
| Interaction | NFIX interactions | 9.48e-05 | 227 | 162 | 9 | int:NFIX | |
| Interaction | HCFC2 interactions | 9.91e-05 | 92 | 162 | 6 | int:HCFC2 | |
| Interaction | LHX2 interactions | 1.19e-04 | 183 | 162 | 8 | int:LHX2 | |
| Interaction | TLX3 interactions | BCL9L NCOA6 PROSER1 CIC IRF9 ARID1B KMT2D TLE1 ARID2 SMARCA2 | 1.27e-04 | 291 | 162 | 10 | int:TLX3 |
| Interaction | OTUD4 interactions | 1.27e-04 | 236 | 162 | 9 | int:OTUD4 | |
| Interaction | SRF interactions | 1.34e-04 | 139 | 162 | 7 | int:SRF | |
| Interaction | HCFC1 interactions | 1.34e-04 | 293 | 162 | 10 | int:HCFC1 | |
| Interaction | UBAP2L interactions | TUT4 CEP85 UBAP2 PUM2 CDKL5 FAM120A UBAP2L PRRC2A YTHDF2 PRRC2B | 1.54e-04 | 298 | 162 | 10 | int:UBAP2L |
| Interaction | SMC5 interactions | NCOA6 PCBP3 UBAP2 DEAF1 GATAD2A MAP4 RBM33 BICRA DIDO1 CHD8 RFX1 ADAR CIC ARID1B UBN1 UBAP2L ARID2 CLTC PRRC2A YTHDF2 | 1.58e-04 | 1000 | 162 | 20 | int:SMC5 |
| Interaction | EYA4 interactions | 1.59e-04 | 243 | 162 | 9 | int:EYA4 | |
| Interaction | CEBPA interactions | NCOA6 DEAF1 GATAD2A MAP4 RBM33 BICRA KDM3B DIDO1 CC2D1A CHD8 RFX1 ADAR CIC KANSL3 ARID1B KMT2D FAM120A ARID2 CLTC SMARCA2 NCOA1 PRRC2A PRRC2B | 1.60e-04 | 1245 | 162 | 23 | int:CEBPA |
| Interaction | YTHDF1 interactions | CEP85 UBAP2 PUM2 CDKL5 FAM120A UBAP2L HSF4 PRRC2A YTHDF2 PRRC2B | 1.71e-04 | 302 | 162 | 10 | int:YTHDF1 |
| Interaction | HOXB2 interactions | 1.94e-04 | 36 | 162 | 4 | int:HOXB2 | |
| Interaction | RNF214 interactions | 1.95e-04 | 104 | 162 | 6 | int:RNF214 | |
| Interaction | KDM3A interactions | 2.04e-04 | 67 | 162 | 5 | int:KDM3A | |
| Interaction | USP27X interactions | 2.16e-04 | 37 | 162 | 4 | int:USP27X | |
| Interaction | KCNA3 interactions | EHBP1 MAP4 NACA AAK1 ZDHHC5 PTPN23 CC2D1A NIBAN2 ADCY9 STT3B UBAP2L DIAPH3 BSN ARHGEF26 PRRC2A PALLD YTHDF2 OTOG | 2.31e-04 | 871 | 162 | 18 | int:KCNA3 |
| Interaction | ETV4 interactions | 2.34e-04 | 69 | 162 | 5 | int:ETV4 | |
| Interaction | SYNE3 interactions | CEP85 PEX1 CC2D1A PROSER1 NCKAP5L RTN1 ADCY9 STT3B DCP1B LPP NOTCH2 PRRC2B | 2.58e-04 | 444 | 162 | 12 | int:SYNE3 |
| Interaction | CNOT3 interactions | 2.77e-04 | 207 | 162 | 8 | int:CNOT3 | |
| Interaction | PRRC2B interactions | 3.02e-04 | 265 | 162 | 9 | int:PRRC2B | |
| Interaction | SESTD1 interactions | 3.23e-04 | 41 | 162 | 4 | int:SESTD1 | |
| Interaction | RAB9A interactions | EHBP1 CDX2 ZDHHC5 PTPN23 CC2D1A NIBAN2 WASHC2A RTN1 ADCY9 STT3B WDR91 MAVS NOTCH2 HTT | 3.30e-04 | 595 | 162 | 14 | int:RAB9A |
| Interaction | ZYX interactions | 3.40e-04 | 329 | 162 | 10 | int:ZYX | |
| Interaction | TBXT interactions | 3.52e-04 | 116 | 162 | 6 | int:TBXT | |
| Interaction | SMARCA4 interactions | CDX2 BICRA KDM6B CIC ARID1B UBN1 ARID2 SMARCA2 NCOA1 MYOCD HSF4 MRTFA | 3.69e-04 | 462 | 162 | 12 | int:SMARCA4 |
| Interaction | LHX4 interactions | 3.97e-04 | 166 | 162 | 7 | int:LHX4 | |
| Interaction | PTK2B interactions | 4.04e-04 | 119 | 162 | 6 | int:PTK2B | |
| Interaction | EYA2 interactions | 4.41e-04 | 121 | 162 | 6 | int:EYA2 | |
| Interaction | FBXW11 interactions | AMER1 NACA MTSS1 PEX1 CHD8 NCKAP5L ADAR FAM120A UBAP2L CLTC PRRC2A PALLD | 4.56e-04 | 473 | 162 | 12 | int:FBXW11 |
| Cytoband | 9q34.13 | 5.89e-05 | 21 | 166 | 3 | 9q34.13 | |
| Cytoband | 12q13.12 | 3.57e-04 | 38 | 166 | 3 | 12q13.12 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | GATAD2A RBM33 BICRA TEAD3 NCKAP5L CIC KMT2D UBAP2L TNK2 HSF4 PRRC2A CYBA | 1.30e-06 | 338 | 161 | 12 | M17094 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | ZC3H12A TUT4 RBM33 BICRA AAK1 DIDO1 ANKMY1 NIBAN2 PPP1R15A LMTK3 RFX1 CASZ1 IRF9 KRBA1 TNK2 | 9.19e-06 | 634 | 161 | 15 | M40866 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DIP2B TUT4 RAPH1 RBM33 PCLO SH3KBP1 MTSS1 PEX1 DND1 RTN1 CASZ1 SLC4A1 DACT1 GLRA2 MAST1 ZFHX2 TNK2 IRF2BPL BSN PRRC2B | 1.57e-05 | 1106 | 161 | 20 | M39071 |
| Coexpression | GSE15215_CD2_POS_VS_NEG_PDC_UP | 2.89e-05 | 195 | 161 | 8 | M3519 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 3.22e-05 | 198 | 161 | 8 | M8041 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 3.34e-05 | 199 | 161 | 8 | M9443 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 3.34e-05 | 199 | 161 | 8 | M7319 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 3.46e-05 | 200 | 161 | 8 | M9439 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TUT4 RBM33 SH3KBP1 MBP AAK1 PUM2 PPP1R15A WNK1 CCDC88B ADAR ZC3H6 STT3B PTK2B ZNF800 KMT2D ATXN7 ARID2 SMARCA2 NCOA1 TNK2 NOTCH2 PRRC2B CYBA | 4.35e-05 | 1492 | 161 | 23 | M40023 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NCOA6 ZNF628 KDM3B KDM6B WNK1 DENND2B UBAP2L LPP CLTC SMARCA2 MYOCD PALLD | 4.76e-05 | 484 | 161 | 12 | MM999 |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 6.39e-05 | 161 | 161 | 7 | M11857 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 7.88e-05 | 14 | 161 | 3 | M1353 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 7.88e-05 | 14 | 161 | 3 | MM565 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 8.97e-05 | 294 | 161 | 9 | M40873 | |
| Coexpression | MYC_UP.V1_DN | 9.68e-05 | 172 | 161 | 7 | M2708 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-08 | 197 | 161 | 9 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-07 | 188 | 161 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-07 | 188 | 161 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-07 | 188 | 161 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-07 | 188 | 161 | 8 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.11e-07 | 192 | 161 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.44e-06 | 153 | 161 | 7 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 101 | 161 | 6 | af4a84e4993d4e80c834e1591556b3b3781deaf3 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 159 | 161 | 7 | cdbccb83af6220bab300dfe56443ff69f6e2043a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.52e-06 | 175 | 161 | 7 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 175 | 161 | 7 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-06 | 182 | 161 | 7 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-06 | 182 | 161 | 7 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-06 | 182 | 161 | 7 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-06 | 182 | 161 | 7 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-06 | 192 | 161 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.69e-06 | 193 | 161 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 195 | 161 | 7 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 195 | 161 | 7 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.23e-06 | 128 | 161 | 6 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-06 | 197 | 161 | 7 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.17e-06 | 199 | 161 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.17e-06 | 199 | 161 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.45e-06 | 200 | 161 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.45e-06 | 200 | 161 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.45e-06 | 200 | 161 | 7 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 159 | 161 | 6 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.76e-05 | 162 | 161 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.06e-05 | 165 | 161 | 6 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-05 | 168 | 161 | 6 | 0372c06b70f0ba95bf8cd1363ca7c5f31207f094 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 170 | 161 | 6 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.62e-05 | 170 | 161 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 170 | 161 | 6 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 170 | 161 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 104 | 161 | 5 | 060f0baca239ab89c18be40c1aa31931f4791b62 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 177 | 161 | 6 | 235254c08b44c20ee3cb62dd2ca0c7e46a2587e3 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 177 | 161 | 6 | b59d9fcf0a4964ef2d6274b6021a69cf7d335e0a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 177 | 161 | 6 | f55332fe7fc32c23892ccf08b6b4d5b1ffcc0d3f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-05 | 178 | 161 | 6 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.45e-05 | 183 | 161 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.45e-05 | 183 | 161 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.62e-05 | 184 | 161 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 185 | 161 | 6 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 185 | 161 | 6 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.79e-05 | 185 | 161 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 187 | 161 | 6 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 189 | 161 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-05 | 190 | 161 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-05 | 191 | 161 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | 43228bddca2f606ddcae9731f04c6b1502c4b85a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | f5463c6bcc5c69ac562bec028f7a105c471f2fbe | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | 18e11d515147accef9aee26e934b358b445e18e2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.31e-05 | 193 | 161 | 6 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.31e-05 | 193 | 161 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | 7766f495f2f945802ef9a5b994cd00bb64d0dfe3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-05 | 194 | 161 | 6 | 3211d89440a6f4a9b3d4cfb755890816944242ec | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.53e-05 | 194 | 161 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 7.53e-05 | 194 | 161 | 6 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.74e-05 | 195 | 161 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.74e-05 | 195 | 161 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 195 | 161 | 6 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 195 | 161 | 6 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | distal-3-Epithelial-Ionocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.96e-05 | 196 | 161 | 6 | 6ed146481dd04fb271eadc47d68eb3ae38986db6 | |
| ToppCell | mLN-T_cell-Th1|T_cell / Region, Cell class and subclass | 8.19e-05 | 197 | 161 | 6 | 5e39a49dddef04469ff2b615d755ddf6a926e58e | |
| ToppCell | distal-Epithelial-Ionocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.19e-05 | 197 | 161 | 6 | 11a5d2db2561d045756980ead61e1211c7dda100 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.19e-05 | 197 | 161 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | distal-Epithelial-Ionocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.19e-05 | 197 | 161 | 6 | 7a2cd970fe0866057999e40d15367b2b3324ae59 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 8.42e-05 | 198 | 161 | 6 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.42e-05 | 198 | 161 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.42e-05 | 198 | 161 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.66e-05 | 199 | 161 | 6 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 8.66e-05 | 199 | 161 | 6 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-05 | 199 | 161 | 6 | 3788f3218356aaaa10684e48d63757037f8a3a3c | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.90e-05 | 200 | 161 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.90e-05 | 200 | 161 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | ZC3H12A PDE4A DEAF1 MAP4 SYNJ2 CASKIN2 HPS6 SMARCA2 NCOA1 ARHGEF26 | 1.32e-06 | 196 | 160 | 10 | 6227_DN |
| Drug | BT325 | 5.09e-06 | 36 | 160 | 5 | CID000068933 | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-05 | 195 | 160 | 9 | 1649_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 7346_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 3836_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 2975_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 2133_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 3307_UP | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; HL60; HT_HG-U133A | 6.37e-05 | 191 | 160 | 8 | 1328_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.61e-05 | 192 | 160 | 8 | 4104_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 4289_UP | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 7.11e-05 | 194 | 160 | 8 | 263_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 3409_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 6614_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 7.64e-05 | 196 | 160 | 8 | 2044_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 5298_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 5318_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 1686_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; HL60; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 1870_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 2796_DN | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 4974_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3250_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3247_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 2392_DN | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6503_UP | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 5284_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 3434_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 4812_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6841_DN | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 8.49e-05 | 199 | 160 | 8 | 900_DN | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 7058_UP | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 4571_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HG-U133A | 8.80e-05 | 200 | 160 | 8 | 702_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 5230_DN | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; PC3; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 4605_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; PC3; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 4086_DN | |
| Drug | levoglucosan | 9.25e-05 | 13 | 160 | 3 | CID000079029 | |
| Drug | trimethoprim-sulfamethoxazole | 1.02e-04 | 66 | 160 | 5 | CID000358641 | |
| Disease | serum albumin measurement | GATAD2A MAP1A RAPH1 MAP4 SH3KBP1 ZFPM1 ADAR ADCY9 PPP4R4 FARP2 ZNF800 NYNRIN IRF2BPL BSN LILRB5 | 6.99e-07 | 592 | 157 | 15 | EFO_0004535 |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 8.12e-06 | 8 | 157 | 3 | DOID:4479 (is_implicated_in) | |
| Disease | Pseudohypoaldosteronism, Type I | 1.73e-05 | 10 | 157 | 3 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.73e-05 | 10 | 157 | 3 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.73e-05 | 10 | 157 | 3 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.73e-05 | 10 | 157 | 3 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.73e-05 | 10 | 157 | 3 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.73e-05 | 10 | 157 | 3 | C1449842 | |
| Disease | calcium measurement | NCOA6 MAP1A AAK1 CHD8 ZFPM1 PPP4R4 SLC4A1 FARP2 ARID1B CELSR2 CASKIN2 NYNRIN MYO18B | 3.36e-05 | 628 | 157 | 13 | EFO_0004838 |
| Disease | Coffin-Siris syndrome | 4.06e-05 | 13 | 157 | 3 | C0265338 | |
| Disease | testosterone measurement | DIP2B NCOA6 PDE4A AMER1 MAP1A SLC22A11 NIBAN2 KDM6B ADAR ADCY9 FARP2 DACT1 ZNF800 ARID1B NYNRIN SMARCA2 NCOA1 MYOCD | 1.59e-04 | 1275 | 157 | 18 | EFO_0004908 |
| Disease | Pseudohypoaldosteronism type 2A | 1.68e-04 | 4 | 157 | 2 | cv:C1840389 | |
| Disease | Pseudohypoaldosteronism, type 2 | 1.68e-04 | 4 | 157 | 2 | cv:C1449844 | |
| Disease | Metastatic melanoma | 1.98e-04 | 54 | 157 | 4 | C0278883 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.01e-04 | 157 | 157 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | dyslexia | 2.38e-04 | 162 | 157 | 6 | EFO_0005424 | |
| Disease | Chronic granulomatous disease | 2.78e-04 | 5 | 157 | 2 | cv:C0018203 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.78e-04 | 5 | 157 | 2 | C3281201 | |
| Disease | JT interval | 3.81e-04 | 248 | 157 | 7 | EFO_0007885 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 4.16e-04 | 6 | 157 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | intellectual disability (is_implicated_in) | 5.40e-04 | 30 | 157 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | grapefruit juice consumption measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0010094 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.38e-04 | 195 | 157 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | alpha-1-antitrypsin measurement | 9.88e-04 | 9 | 157 | 2 | EFO_0008327 | |
| Disease | vein graft stenosis | 9.88e-04 | 9 | 157 | 2 | EFO_0007051 | |
| Disease | urate measurement | NCOA6 MAP4 SLC22A11 AAK1 PLPP7 CHRM1 STT3B SLC4A1 FARP2 MYO18B ARHGEF26 NOTCH2 PRRC2B | 1.04e-03 | 895 | 157 | 13 | EFO_0004531 |
| Disease | thioredoxin domain-containing protein 12 measurement | 1.17e-03 | 39 | 157 | 3 | EFO_0008298 | |
| Disease | tauopathy (implicated_via_orthology) | 1.23e-03 | 10 | 157 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 1.23e-03 | 10 | 157 | 2 | EFO_0008465 | |
| Disease | Paroxysmal atrial fibrillation | 1.51e-03 | 156 | 157 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.51e-03 | 156 | 157 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.51e-03 | 156 | 157 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.69e-03 | 160 | 157 | 5 | C0004238 | |
| Disease | sunburn | 1.75e-03 | 96 | 157 | 4 | EFO_0003958 | |
| Disease | Amelogenesis Imperfecta | 1.79e-03 | 12 | 157 | 2 | C0002452 | |
| Disease | dickkopf‐related protein 1 measurement | 1.79e-03 | 12 | 157 | 2 | EFO_0010620 | |
| Disease | Malignant neoplasm of breast | BOC EHBP1 NCOA6 RAPH1 ADAMTS1 WNK1 ADAR CIC ARID1B KMT2D SYNJ2 NCOA1 PRRC2A NOTCH2 | 1.85e-03 | 1074 | 157 | 14 | C0006142 |
| Disease | QRS-T angle | 2.52e-03 | 106 | 157 | 4 | EFO_0020097 | |
| Disease | Intellectual Disability | 2.80e-03 | 447 | 157 | 8 | C3714756 | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.17e-03 | 55 | 157 | 3 | C0079744 | |
| Disease | diastolic blood pressure, systolic blood pressure | CEP85 GATAD2A RBM33 DENND2B CASZ1 ZNF800 ARID1B ZNF764 MYOCD CYBA | 3.23e-03 | 670 | 157 | 10 | EFO_0006335, EFO_0006336 |
| Disease | ischemia (implicated_via_orthology) | 3.63e-03 | 17 | 157 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 4.05e-03 | 121 | 157 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | monocyte count | ZC3H12A CDX2 DIDO1 ZFPM1 WNK1 DENND2B CIC CASZ1 ADCY9 WDR91 PTK2B LPP MAST1 NCOA1 MRTFA | 4.68e-03 | 1320 | 157 | 15 | EFO_0005091 |
| Disease | parental longevity | 5.10e-03 | 494 | 157 | 8 | EFO_0007796 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 5.29e-03 | 66 | 157 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | breast carcinoma (is_marker_for) | 5.29e-03 | 66 | 157 | 3 | DOID:3459 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSVPPLQGLGKAAGP | 71 | Q6ZR03 | |
| LSGQPSLQPPASPQL | 171 | Q96P26 | |
| APAGIQAPPQSAAKP | 96 | Q9ULZ3 | |
| QGPIKPVSPNSSPFG | 516 | Q9P2B4 | |
| GKEQSVLAPQPGPGP | 311 | Q8NCV1 | |
| LLQTLNPGPPGPAAT | 136 | Q99626 | |
| NPGATGPPLKPAVTL | 261 | Q9HCK8 | |
| LPPLGSEPAKPTNGG | 346 | Q8IYX3 | |
| LPRPTGSFPQNPLGK | 601 | A0A096LP49 | |
| PASVAPPQGPGTKIQ | 601 | A6NC98 | |
| PPQGPGTKIQAPQLL | 606 | A6NC98 | |
| LQAKPVAPQVPSPGG | 21 | Q5T035 | |
| PKPQGPLPNTALLSL | 561 | P02730 | |
| SNQPGLLASVPQPKP | 406 | Q2M2I8 | |
| KNFDRVPPSQGPPGL | 1331 | Q86V15 | |
| PQPQKKGLPSPQGTR | 1856 | Q96L96 | |
| GNPKPQLPIGAIPSS | 116 | Q68CP9 | |
| STPGGKLILPAPQIP | 1071 | Q68CP9 | |
| GFSPSPLPQAKPVGI | 1066 | Q5JTC6 | |
| PLPQAKPVGITHGIP | 1071 | Q5JTC6 | |
| LPKAVPGGSPKSPAN | 116 | Q96DR7 | |
| PKLQPPSPANSGSLQ | 1246 | Q8NFD5 | |
| NKPLLGQTGLPQGPS | 1461 | Q9HCU4 | |
| GQNSPPLPILPFGLK | 621 | Q9NSV4 | |
| KPGTPGNSPSSQRLP | 361 | P78524 | |
| ALNPGPKGQPESLSP | 1351 | Q9UKP4 | |
| NLFLPPQGGGKPPSS | 686 | Q07912 | |
| QALSPSPTNGNPLLP | 846 | Q96EV2 | |
| PAAPPKPGKLNLSGV | 1021 | Q70E73 | |
| KPQNPIQLPGDLPGT | 466 | Q9UHI8 | |
| GPPAPTTQAQPDLIK | 681 | Q9UL03 | |
| LPPGTYSGPTQLIQP | 791 | Q9H3S7 | |
| PSEGLGPLPNPTANK | 196 | Q8TB72 | |
| PLLNGAPAGESPQPK | 671 | Q96TA1 | |
| PPLVRGTQNIPAGKP | 191 | Q86YP4 | |
| PSPANFIQPGKQPLL | 436 | A6NGU5 | |
| PKGSIAQPAGAPQPQ | 2311 | Q04721 | |
| LKGIPPNGSSPSQLP | 391 | A5PL33 | |
| APILSKGPSPPLNGN | 2066 | P78559 | |
| SSPAAGIPQKPQGAP | 51 | P43366 | |
| GIPQKPQGAPPTTTA | 56 | P43366 | |
| KPPGAVPSNALTNPA | 331 | Q7Z434 | |
| PTSLPKQPAPTTIGG | 721 | P27816 | |
| PSSKAPGRPQLSPGQ | 321 | P19878 | |
| EKSPSPGGPQLSPQL | 466 | Q9HCH0 | |
| NLTAQAAPRGPKGPP | 226 | Q93015 | |
| PGLATSPPFQLTKPG | 266 | O15054 | |
| APGPLGPAPKNGTLE | 1071 | Q96Q04 | |
| SPLKQKGPQGLGQPS | 551 | Q9UPA5 | |
| LGQPSGPLPAKASPL | 561 | Q9UPA5 | |
| RPQIGGTIKQPPSNP | 141 | P13498 | |
| QPIQQPSGPGEVKLP | 566 | Q12766 | |
| GRVPAQSGPLPKPSL | 16 | Q9HCN6 | |
| QSGPLPKPSLQALPS | 21 | Q9HCN6 | |
| PLPPLPLTRKSNGGQ | 311 | Q9HCN6 | |
| GGPQLTVPPNLLPQT | 246 | Q9H1B7 | |
| PPAQPSGLTKPLAQQ | 331 | Q9Y6V0 | |
| LAQPPGVGKTPAQQP | 391 | Q9Y6V0 | |
| GTPKPLAQQPGLQSP | 416 | Q9Y6V0 | |
| AQQTGPTKPPSQLPG | 461 | Q9Y6V0 | |
| LGGDLAPVPSSPQPK | 646 | Q9Y6V0 | |
| SGQASVNPPLPGPKP | 666 | O43312 | |
| VPVPSNKRSPLGGPT | 201 | P27815 | |
| KNFTILQGPPGPRGP | 436 | Q5KU26 | |
| GVQTPSKGTPAPLPN | 956 | Q8IX07 | |
| NLPKPRQKQPGVGPA | 941 | Q9P265 | |
| NKPGGDLPALSPSPI | 1121 | Q5T7B8 | |
| PGKLPQTPLDTGIPF | 1301 | Q7LBC6 | |
| PQAGPIPVAPIGTLK | 186 | Q93052 | |
| LPKGPSQALFPVGPV | 171 | O75023 | |
| SLQAKPVAPQVPSPG | 371 | Q9NZB2 | |
| GLPGPVLPLNLAKNP | 401 | Q9BZE0 | |
| LLQPGKDNPPNIPSS | 406 | Q15070 | |
| PKPTLPSPGQILNGK | 296 | O15265 | |
| PSPGQILNGKGLPAP | 301 | O15265 | |
| GNLTIKQRPKPAGPP | 956 | Q8WXE0 | |
| IPPGVPALPVKNLNG | 311 | Q86Y01 | |
| QTGVSSFKPGPLPPN | 356 | Q8IZQ8 | |
| PVPPASLLGSGTKPQ | 1526 | Q9Y2H9 | |
| PLGQTNPAFPGEKLP | 256 | P57721 | |
| NLLPPLGLSQSGPPG | 216 | A6NF01 | |
| GLPLPLPPTSQGLSN | 431 | Q86XN7 | |
| QPPPAAVNALGLPKG | 861 | Q8WX93 | |
| LPSGALQPPPAQGSL | 321 | Q14686 | |
| VTPVAPGKGLAQPPQ | 391 | Q8IZD4 | |
| SKPRGTSPLPAGQVP | 176 | P62683 | |
| SKPRGTSPLPAGQVP | 176 | P63145 | |
| SKPRGTSPLPAGQVP | 176 | Q7LDI9 | |
| SKPRGTSPLPAGQVP | 176 | P62685 | |
| SKPRGTSPLPAGQVP | 176 | P63126 | |
| SKPRGTSPLPAGQVP | 176 | P62684 | |
| LGQPSPKQQPLEPGE | 106 | Q92838 | |
| LPGPAQAGAGQPLPK | 41 | Q6PRD7 | |
| PGPAIKAALPSLTNP | 1161 | P42858 | |
| TGLLPKPSLLAQPGP | 1061 | Q8N6C5 | |
| TLGDPNKLPEGVPQP | 26 | Q9Y2M5 | |
| GTPPVSPSKLGNPEQ | 426 | Q9BWV1 | |
| QKNSLQGVPPATPPL | 511 | Q9NYF0 | |
| VIGKQTPSLPPSLPG | 56 | P55265 | |
| TGLKGPAAPLTPGPQ | 161 | O75398 | |
| PTPTKAAPPALVNGL | 431 | O75398 | |
| LQPTKPLVATSPNPG | 76 | O60883 | |
| GLQPAPGLSKPLPSQ | 251 | Q6P2H3 | |
| SANPPGPLKSPQVLG | 966 | Q86UU0 | |
| IVKGINLPTPPGLSP | 661 | Q6P1N0 | |
| APPGSAVGKQPAPRN | 551 | Q9BTC0 | |
| PPAVSPNITVLAPGK | 6 | P11229 | |
| GGPNPKTQNGLLSPP | 666 | O60503 | |
| PSSLKLSNEPGPPQA | 631 | Q9P2S6 | |
| APAPPVLSPKTGVLN | 401 | Q8NDI1 | |
| LKVSPQQPGPSGSAP | 31 | O14645 | |
| GTAVKATPANPLPQP | 386 | P23416 | |
| LNSPSPGKDPTLGAP | 436 | Q9ULV5 | |
| NIVTPRTPPPSQGKG | 226 | P02686 | |
| LPSPGPAPGQIALLK | 171 | Q8IYX4 | |
| PPGIVSGQPGTQKVP | 116 | Q00978 | |
| NPSPGPAPQATSVKL | 771 | Q9P2N6 | |
| TVAPLGPKPGPVVRN | 416 | Q9NRM1 | |
| EFTGPPQKPPRLGAQ | 851 | Q14289 | |
| PQKPPRLGAQSIQPT | 856 | Q14289 | |
| LGPPALQPGPGLSTK | 461 | O94887 | |
| LQPGPGLSTKSPQPS | 466 | O94887 | |
| ITAGKEPPNGILPPF | 551 | Q86YV9 | |
| QIPAAAPLKGPGPSS | 761 | Q9NZM4 | |
| QEPAPKGRPALQLPG | 891 | O76039 | |
| PKALLTISIPPGPNQ | 66 | Q9NSA0 | |
| GTQVPGTPPPKYNTL | 616 | P51170 | |
| LPGVPGKDQLFSQPP | 1161 | O43933 | |
| PGPQSSAPAQRPQLK | 286 | O75807 | |
| GPAPVLPTGQGKPVA | 511 | Q9P2P1 | |
| LGNETLPPSQGLPTP | 1476 | Q6ZRI0 | |
| NQSPAATKGPGPLGP | 561 | Q16799 | |
| LQLAKQTSGPAGPPG | 306 | Q7Z736 | |
| PPQQAGSPLKPAAPA | 481 | Q3ZLR7 | |
| KGELSPVPPNVPLSQ | 1866 | O60522 | |
| QSLPKNIPISVPGPS | 741 | Q6NUP7 | |
| GPELSGPSTPQKLPV | 266 | P51531 | |
| PGAPQQPPKARTGIS | 1146 | O15056 | |
| VQPTSGPGPRPSLAK | 101 | Q8NDG6 | |
| APKPGPVQPLTVQGL | 256 | P22670 | |
| QPGPLGTQKPTSGPQ | 1411 | Q15788 | |
| PPPSAPVIKQGAGTT | 341 | Q96B97 | |
| LGGPKETPPNGNLSP | 991 | P48634 | |
| ELKQGPNPLAPSPSA | 71 | Q9H2Y9 | |
| PGTPGPLNRQATPLL | 101 | Q2M3G4 | |
| VSPPGPLTKGNLPVV | 201 | A6NGB9 | |
| GPPGQPPLKLIQAVA | 426 | Q92935 | |
| PAPAPLGTPVKQENS | 566 | Q969V6 | |
| SKPRGTSPLPAGQVP | 176 | P63128 | |
| SLLPGEPPQKIPTGV | 676 | P63128 | |
| LQVAPAPAPAPGTKA | 836 | Q96RK0 | |
| IEVGTPPTGNQPFPK | 231 | Q00610 | |
| TIPPNLAGIPGGKPA | 431 | Q04724 | |
| PLVTSGKAPPNLPQG | 786 | Q5T6F2 | |
| PQKPSPNVGVTLEGP | 1096 | P61129 | |
| LPLVPRGGGTPKAPN | 106 | Q5D1E8 | |
| ATTSGKAPPNLPPGV | 781 | Q14157 | |
| ATLASGPQPFLPPGK | 1971 | Q9C0A1 | |
| RKAAPPQGGPPISIT | 2521 | Q9C0A1 | |
| TPLAPKGAAPGAVQP | 106 | Q5TF21 | |
| PKPAPAGLSGGLSQP | 51 | Q8TCJ2 | |
| PLLGQQPGPSQDIKP | 166 | Q99594 | |
| PVAAGSPGLKAPQAP | 136 | Q9BV97 | |
| KSNPPGLGVPTPQTL | 76 | Q8IYM1 | |
| PATPGIGAPGNKPEL | 6 | Q9UK41 | |
| PPESLPQPGLQKSVS | 106 | Q5JSZ5 | |
| PLNITNKPGLPVIPG | 941 | Q6AHZ1 | |
| NKPGLPVIPGNALPL | 946 | Q6AHZ1 | |
| LQPRGPSVPSAGKVP | 611 | Q8IUG5 | |
| QPKSLGSASPGPGQP | 676 | Q9C0B5 | |
| ENPANPPVGGKAKSP | 1156 | Q641Q2 | |
| SQKLTLVAPPGGPNG | 961 | Q9NPG3 | |
| PLRQGASPRGPKPQL | 61 | Q86TV6 | |
| PGDPPLLQQPLQTSK | 26 | Q2TB10 | |
| PTSPKQGSLPDIQGP | 1161 | Q9H7P9 | |
| AALVQLPAKQPPPGT | 66 | Q96KN8 | |
| LPAKQPPPGTLEQGR | 71 | Q96KN8 | |
| PTGPAGLRRTPNKQP | 161 | Q8WTV1 | |
| TPGPKPPAVVSQQAA | 1466 | Q9H4A3 | |
| RKPLPPNNVTGKPGS | 711 | Q7Z7G0 | |
| PSSQPGSQPKLGPPQ | 1446 | Q5TAX3 | |
| LSPAQGPPQPQSSAK | 276 | A4D1P6 | |
| RLGKQPPPGIVAPAA | 1166 | Q96J92 | |
| KNGIAGSSLPPPPIK | 256 | Q9Y5A9 | |
| PVAAGSPGLKSPQAP | 126 | Q96H86 | |
| EFLSLNQPPKGGPEP | 21 | Q8NBV4 | |
| LTEPPATGPPGQKLL | 961 | Q5EBL2 | |
| NQALGPKPQGLMPPS | 3766 | O14686 | |
| QPPKPGPVLQSGQGL | 4171 | O14686 | |
| LQPPENLAKGQPSTP | 1206 | O15069 | |
| PPKQQFLPSSPGLVL | 1811 | E9PAV3 |